Effects of inhaled thrombin receptor agonists in mice
Open Access
- 1 September 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 143 (2), 269-275
- https://doi.org/10.1038/sj.bjp.0705926
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused LiversThe Journal of pharmacology and experimental therapeutics, 2003
- Role of protease-activated receptors in airway function: a target for therapeutic intervention?Pharmacology & Therapeutics, 2002
- International Union of Pharmacology. XXVIII. Proteinase-Activated ReceptorsPharmacological Reviews, 2002
- Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungsSeminars in Immunology, 2002
- Role of thrombin and its major cellular receptor, protease-activated receptor-I, in pulmonary fibrosisBiochemical Society Transactions, 2002
- Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2001
- Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanismBritish Journal of Pharmacology, 2001
- Resistance to thromboembolism in PI3Kγ‐deficient miceThe FASEB Journal, 2001
- Structure-Function Analysis of Protease-activated Receptor 4 Tethered Ligand PeptidesOnline Journal of Public Health Informatics, 2000
- Thrombin functions as an inflammatory mediator through activation of its receptor.The Journal of Experimental Medicine, 1996